New Nanotherapy May Help Reduce Recurrent Heart Attacks and Stroke

A recent report in the journal of Nature Communications showcased the development of a new technology that may provide a solution for controlling inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. A research team designed and tested a high-density lipoprotein (HDL) nanoparticle loaded with a statin drug. In mouse studies, the HDL nanotherapy was capable of directly targeting and lowering dangerous inflammation in blood vessels. According to the senior investigator of the study, HDL nanotherapy could potentially avert repeat heart attacks and reduce recurrent strokes caused by clots in brain arteries. To find out more about this study, click here.